Amid questions about the late boxing great’s symptoms, UF’s Dr. Michael Okun and colleagues conclude his primary diagnosis was young-onset Parkinson’s disease.
AMX0035 was tested at UF, Mass General and partnering sites and then approved by the FDA to treat ALS.
Dr. Shannon Chiu awarded five-year grant from NIA to investigate changes in LBD using diffusion-weighted MRI and task-based EEG.
Dr. Michael Okun featured in story highlighting the expanding field of brain stimulation for conditions from movement disorders to addiction.
Dr. Michael Okun featured in AARP article about increased research funding for Parkinson’s.
Dr. Aysegul Gunduz was named the inaugural Fixel Brain Mapping Professor.
Article in journal Tremor underscores need to improve delivery of care to underserved populations.
Drs. Michael Okun and Michael Jaffee contributed to a recent edition of NEJM Group publication.
Dr. Michael Okun co-authored wide-ranging review of Parkinson’s disease.
The program trains doctoral students to become independent researchers in Parkinson’s disease, dystonia, tremor and ataxia.